CAPHRA urges Australia to change stance on e-cigarettes

Dec.28.2022
CAPHRA urges Australia to change stance on e-cigarettes
CAPHRA urges Australia's new government to change its stance on e-cigarettes as numbers of users continue to rise.

The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has urged the new Australian government to reconsider its stance against electronic cigarettes.


As of October 1st, electronic cigarette users in Australia can only purchase e-cigarette products from a pharmacy with a prescription. This is in contrast to neighboring New Zealand and most other countries, where retailers can sell nicotine products over the counter. However, anyone who violates Australian regulations will face hefty fines and, in severe cases, imprisonment.


At the same time, the latest report from the National Household Survey on Drug Strategy states that although over 2.5 million Australians still smoke, the number of people using e-cigarettes was 240,000 in 2016 and 520,000 in 2019. If this trend continues, there could be up to 600,000 Australians using e-cigarettes currently.


CAPHRA has emphasized that the local, hard-line approach to electronic cigarettes is increasingly out of sync with other Asia-Pacific countries. The new government and the next Health Minister must support tobacco harm reduction (THR) methods, including providing safer alternatives to smokers. CAPHRA Coordinator, Nancy Loucas, said, "We hope the Liberal Party will end the public war on nicotine products that has been going on for nearly a decade.


Former Health Minister Greg Hunt and his cabinet colleagues oversaw a failed "quit or die" approach to tobacco control. As a result, Australia's overall smoking rates have hardly budged, while other countries have achieved significant success. "To save thousands of Australian lives every year, the new government must urgently adopt a completely different strategy," Loucas said.


According to a recent press release by CAPHRA, Australian tobacco harm reduction (THR) expert Dr. Colin Mendelsohn has recently described Australia's past decade of anti-smoking strategies as "embarrassing failures," and the numbers confirm it. In 2018, a target was set for adults to reduce smoking by 10% per day, but only 13.8% was achieved, with smoking rates now at a stable level.


Dr. Alexander David Wodak, a renowned advocate for reducing drug harm in Australia, has long argued that the same approach needed for smoking. In a recent interview with ABC, Dr. Wodak explained how Australia has taken the wrong approach to safer nicotine alternatives, causing it to fall behind other countries in smoking rates instead of making progress.


He suggested that "the majority of smokers have low income", therefore, safer nicotine substitutes should not be priced too high in order to encourage smokers to switch to alternatives such as e-cigarettes.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

BAT H1 2025 Trading Update: Velo Volume Share Hits 29.7%, Vuse Revenue Falls 15%, glo Hilo Set for Broader Expansion
BAT H1 2025 Trading Update: Velo Volume Share Hits 29.7%, Vuse Revenue Falls 15%, glo Hilo Set for Broader Expansion
BAT’s H1 2025 revenue slightly beat expectations, with full-year growth forecast at 1–2%. Velo grew to 29.7% share in key markets; U.S. revenue surged. Glo Hilo doubled conversion in Serbia, set for wider rollout. Vuse revenue down ~15% amid illicit competition, but Vuse Ultra launch may aid H2 recovery.
Jun.03 by 2FIRSTS.ai
STMA Launches Special Inspection: Shenzhen Vape Companies Face Major License Renewal Test
STMA Launches Special Inspection: Shenzhen Vape Companies Face Major License Renewal Test
Shenzhen office of the State Tobacco Monopoly Administration (STMA) announced the launch of a month-long special inspection targeting local vape companies.
Jun.12
Tax Stamp System Drives Compliance: E-Cigarettes as Key Revenue Source
Tax Stamp System Drives Compliance: E-Cigarettes as Key Revenue Source
Tax stamp system drives compliance: Philippines BIR chief aims to boost industry compliance and increase revenue through e-cigarette taxation.
Apr.17 by 2FIRSTS.ai
Malaysia Tightens E-Cigarette Regulations, Expands Enforcement to Ads, Packaging, and Sales
Malaysia Tightens E-Cigarette Regulations, Expands Enforcement to Ads, Packaging, and Sales
Malaysia’s Health Ministry has unveiled stricter e-cigarette regulations, covering registration, advertising, packaging, and display—aimed at protecting minors. The health minister noted the rules are dynamic and will be updated as new evidence arises. As for calls for a total ban, he said that falls under local government authority.
Apr.25 by 2FIRSTS.ai
British American Tobacco France Survey: Nearly 70% Back Nicotine Pouch Sales
British American Tobacco France Survey: Nearly 70% Back Nicotine Pouch Sales
According to a commissioned survey by British American Tobacco France, consumer awareness of nicotine pouches in France remains low, particularly among older demographics, with 39% of respondents saying they were unfamiliar with the product. While a majority supports stricter regulation — including higher fines and the introduction of licensing systems — 68% believe adults should be allowed to purchase nicotine pouches. Meanwhile, 86% agree that sales to minors should be prohibited.
Apr.27 by 2FIRSTS.ai
New E-cigarette Products Announced in UK Regulatory Database
New E-cigarette Products Announced in UK Regulatory Database
New e-cigarette products from brands like SKE, ELFBAR, and IVG have been approved for the UK market.
Apr.17 by 2FIRSTS.ai